期刊文献+

FR-167653阻止肝硬化大鼠70%肝切除术后急性肝功能衰竭的实验研究

FR-167653 attenuates acute hepatic failure after partial hepatectomy in cirrhotic rats
下载PDF
导出
摘要 目的探索肿瘤坏死因子-α及白介素-1β双重合成阻断剂-FR-167653在阻止内毒素诱发的肝硬化大鼠70%肝切除术后急性肝功能衰竭中的作用。方法切除二甲基亚硝胺诱导的肝硬化大鼠70%肝脏,48h后静脉注射脂多糖(LPS)诱发急性肝功能衰竭,FR-167653自LPS静脉注射前30min开始静脉给药150min,并设对照组,比较两组存活率、ALT、AST、TNF-α、IL-1β水平及病理改变。结果LPS注药后48h,实验组的生存率明显高于非给药对照组。6hTNF-α及IL-1β血清浓度,6,12hALT和AST血清浓度,两组差异有统计学意义。FR-167653给药减轻了LPS诱发的肝细胞坏死,及肝窦内炎细胞浸润。结论FR-167653能有效阻止内毒素诱发的肝硬化大鼠70%肝切除术后急性肝功能衰竭。 Objective: Proinflammatory cytokines such as tumor necrosis factor-α(TNF-α) and interleckln 1-β(IL-1β)play an important role in the development of hepatic failure after extensive liver resection. FR167653 has been characterized as a potent suppressant of TNF-α and IL-1β. In the present study,we explored the possibility that FR161653(FR) attenuates an acute Ilver InJury Induced by the injection of Lipopolysaccharide (LPS) after partial hepatectomy In clrrhotlc rats. Methods: Dimethylnltrosamine-lnduoed olrrlqotic rats received LPS 48h after 1096 hepatectomy to prepare a lethal posthepatectomy acute liver failure model. FR was adminlstered intravenously at 3mg/(kg·hour)for 150min, starting 30min before LPS challenge, Rsuits :FR slgnlflcantly Improved the survival rate of rats at 48h after LPS challenge. Serum levels of alanine :cransaminase ( ALT ), asPartate transamlnase ( AST ), TNF - α and IL-1β were signficantly lower in the FR-treeted group than that in the control group.Histopethoiogically,liver tissue damege was milder in the FR-treated group than that in the control group.Conelusion:The results indicate that treatment with FR amelicrates an acute liver injury incuced by the injection of endotoxin after partial hepatectomy in cirrhotic rats.
出处 《中国现代普通外科进展》 CAS 2006年第2期83-85,共3页 Chinese Journal of Current Advances in General Surgery
关键词 FR-167653 肝切除术 肝功能衰竭 肝硬化 大鼠 Wistar FR167653 Hepatectomy Liver fallure Liver cirrhosis Rats,Wistar
  • 相关文献

参考文献17

  • 1Yamamoto N,Sakai F,Yamazaki H,et al.Effect of FR:a cytokine suppressive agent on endotoxin-induced disseminated intravascular coagulation[J].Eur J Pharmacol,1996,314(1-2):137-142.
  • 2Yamamoto N,Sakai F,Yamazaki H,et al.FR a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha ameliorates endotoxin-induced shock[J].Eur J Pharmacol,1997,327(2-3):169-174.
  • 3Jenkins SA,Grandison A,Baxter JN,et al.A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat[J].J Hepatol,1985,1(5):489-499.
  • 4Jezequel AM,Mancini R,Rinaldesi ML,et al.A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat[J].J Hepatol,1987,5(2):174-181.
  • 5Higgins GM,Anderson RM.Experimental pathology of the liver.Restoration of the liver of the white rat following partial surgical removal[J].Arch Pathol,1931:12,186-202.
  • 6Mochida S,Ogata Ⅰ,Hirata K,et al.Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats[J].Gastroenterology,1990,99(3):771-777.
  • 7Boermeester MA,Straatsburg IH,Houdijk AP,et al.Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy[J].Hepatology,1995,22(5):1499-1506.
  • 8Simpson KJ,Lukacs NW,Colletti L,et al.Cytokines and the liver[J].J Hepatol,1997,27(6):1120-1132.
  • 9Thornton AJ,Ham J,Kunkel SL.Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide,interleukin-8,in human hepatoma and primary hepatocyte cultures[J].Hepatology,1991,14(6):1112-1122.
  • 10Lukacs NW,Strieter RM,Elner V,et al.Production of chemokines,interleukin-8 and monocyte chemoattractant protein-1,during monocyte:endothelial cell interactions[J].Blood,1995,86(7):2767-2773.

二级参考文献28

  • 1Carreno B M,Collins M .The B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune response[J].Annu Rev Immunol,2002,20:29-53.
  • 2Sharpe A H,Freeman G J.The B7-CD28 superfamily[J].Nat Rev Immunol,2002,2:116-126.
  • 3Shengdian Wang,Liping Chen.Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte response[J].Microbes Infec,2004,6759-6766.
  • 4Dong H,Zhu G,Tamada K,et al.B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J].Nat Med,1999,5:1365-1369.
  • 5Freeman GL,Long AL,Y Iwai,et al.Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J].J Exp Med,2000,192:1027-1034.
  • 6Tseng S Y,Otsuji M,Gorski K,et al.B7-DC,a new dentriticcell molecule with potent costimulatory properties for T cells[J].J Exp Med,2001,193:839-846.
  • 7Latchman Y,Wood C R,Chernove T,et al.PD-L2,a novel B7 homologue,is a second ligand for PD-1 and inhibits T cell activation[J].Nat Immunol,2001,2:261-268.
  • 8Wang S,Bajorath J,Files D B,et al.Molecular modeling and functional mapping of B7-H1 and B7-DC delineate independent binding structures for PD-1 and a costimulatory receptor[J].J Exp Med,2003,197:1083-1091.
  • 9Wang S,Zhu G,Chapoval AI,et al.Costimulation of T cells by B7-H2,a B7-like molecule that binds ICOS[J].Blood,2000,96:2808-2813.
  • 10Hutloff A,Dittrich AM,Beier KC,et al.ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J].Nature,1999,397:263-266.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部